학술논문

Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis.
Document Type
Article
Source
European Heart Journal; 9/1/2022, Vol. 43 Issue 33, p3100-3114, 15p
Subject
PERCUTANEOUS coronary intervention
DRUG-eluting stents
ACUTE coronary syndrome
TREATMENT duration
PLATELET aggregation inhibitors
HEMORRHAGE
Language
ISSN
0195668X
Abstract
Copyright of European Heart Journal is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)